TEN, Ltd. Reports Profits for the Nine Months and Third Quarter Ended September 30, 2025 and Declares Common Share Dividend of $1

Minimum Contracted Revenue Gross Revenues of $577 million and net income of $103 million, or $2.75 per share $1.00 New Common Share ...
The Media Line

Freed Hostage Guy Gilboa-Dalal Says Captor Sexually Assaulted Him

Gilboa-Dalal said the assailant pulled him from the bathroom before he could dress, took him into a nearby room, and forced ...
The Manila Times

RentRedi Earns Top 50 Financial Technology Company Nod for Smart Rent Payment Innovations

This recognition affirms RentRedi’s role as a premier fintech partner empowering real estate investors to operate smarter and ...
Le Lézard

Accord BioPharma, Inc. Announces FDA Approval of Denosumab Biosimilars OSVYRTI® (denosumab-desu) and JUBEREQ® (denosumab-desu)

Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today the U.S. Food and Drug ...